Literature DB >> 10727586

Venlafaxine-induced serotonin syndrome with relapse following amitriptyline.

N K Perry1.   

Abstract

A case of venlafaxine-induced serotonin syndrome is described with relapse following the introduction of amitriptyline, despite a 2-week period between the discontinuation of one drug and the commencement of the other. Electroencephalography may play an important part in diagnosis. With the increasing use of selective serotonin re-uptake inhibitors, greater awareness of the serotonin syndrome is necessary. Furthermore, the potential for drug interactions which may lead to the syndrome needs to be recognised.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727586      PMCID: PMC1741568          DOI: 10.1136/pmj.76.894.254

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

Review 1.  Venlafaxine extended-release: a review of its use in the management of major depression.

Authors:  K Wellington; C M Perry
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  The role of electroencephalography in the diagnosis of serotonin syndrome.

Authors:  Theeba Krishnamoorthy; John Knighton; Louis Merton
Journal:  J Intensive Care Soc       Date:  2016-02-10

Review 3.  Drug-Induced Hyperthermia Review.

Authors:  Michael Horseman; Ladan Panahi; George Udeani; Andrew S Tenpas; Rene Verduzco; Pooja H Patel; Daniela Z Bazan; Andrea Mora; Nephy Samuel; Anne-Cecile Mingle; Lisa R Leon; Joseph Varon; Salim Surani
Journal:  Cureus       Date:  2022-07-26

4.  Linezolid is associated with serotonin syndrome in a patient receiving amitriptyline, and fentanyl: a case report and review of the literature.

Authors:  Lampros Samartzis; Paraskevi Savvari; Sofoklis Kontogiannis; Stavros Dimopoulos
Journal:  Case Rep Psychiatry       Date:  2013-03-04

5.  Linezolid-induced near-fatal serotonin syndrome during escitalopram therapy: case report and review of literature.

Authors:  Ranganath R Kulkarni; Pratibha R Kulkarni
Journal:  Indian J Psychol Med       Date:  2013-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.